Biotech & Health Tech
How Hims plans to revive its business after pivoting to branded GLP-1s
Hims & Hers, once obsessed with delivering "personalized care" through compounded drug products, is now banking on brand-name treatments and the pharmaceutical giants it previously tried to undercut. Hims struck a deal with Eli Lilly ...
Hims & Hers, once obsessed with delivering "personalized care" through compounded drug products, is now banking on brand-name treatments and the pharmaceutical giants it previously tried to undercut. Hims struck a deal with Eli Lilly ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗